Tillkännagivande • Mar 31
Shenzhen Capchem Technology Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Shenzhen Capchem Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Tillkännagivande • Mar 23
Shenzhen Capchem Technology Co., Ltd., Annual General Meeting, Apr 15, 2026 Shenzhen Capchem Technology Co., Ltd., Annual General Meeting, Apr 15, 2026, at 14:00 China Standard Time. Location: 16F, Capchem Technology Building, Changye Road, Pingshan District, Shenzhen, Guangdong China Tillkännagivande • Dec 31
Shenzhen Capchem Technology Co., Ltd. to Report Fiscal Year 2025 Results on Mar 24, 2026 Shenzhen Capchem Technology Co., Ltd. announced that they will report fiscal year 2025 results on Mar 24, 2026 Tillkännagivande • Sep 30
Shenzhen Capchem Technology Co., Ltd. to Report Q3, 2025 Results on Oct 24, 2025 Shenzhen Capchem Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 24, 2025 Tillkännagivande • Jul 02
Shenzhen Capchem Technology Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025 Shenzhen Capchem Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025 Tillkännagivande • Apr 17
Shenzhen Capchem Technology Co., Ltd. Approves Cash Dividend for the Year 2024 Shenzhen Capchem Technology Co., Ltd. at the Annual General Meeting of 2024 held on 15 April 2025 approved cash dividend per 10 shares (tax included) of CNY 4.00000000 for the year 2024. Tillkännagivande • Mar 31
Shenzhen Capchem Technology Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 Shenzhen Capchem Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Tillkännagivande • Mar 26
Shenzhen Capchem Technology Co., Ltd. Proposes Final Cash Dividend for 2024 Shenzhen Capchem Technology Co., Ltd. announced on 25 March 2025 the profit distribution proposal for 2024 as follows: Final Cash dividend per 10 shares (tax included) of CNY 4.00000000. Tillkännagivande • Mar 25
Shenzhen Capchem Technology Co., Ltd., Annual General Meeting, Apr 15, 2025 Shenzhen Capchem Technology Co., Ltd., Annual General Meeting, Apr 15, 2025, at 14:00 China Standard Time. Location: 16F, Capchem Technology Building, Changye Road, Pingshan District, Shenzhen, Guangdong China Tillkännagivande • Dec 31
Shenzhen Capchem Technology Co., Ltd. to Report Fiscal Year 2024 Results on Mar 25, 2025 Shenzhen Capchem Technology Co., Ltd. announced that they will report fiscal year 2024 results on Mar 25, 2025 Valuation Update With 7 Day Price Move • Nov 08
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥43.42, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 39% over the past three years. Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.38 (vs CN¥0.38 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.38 (in line with 3Q 2023). Revenue: CN¥2.08b (down 3.0% from 3Q 2023). Net income: CN¥285.7m (up 1.9% from 3Q 2023). Profit margin: 14% (in line with 3Q 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year whereas the company’s share price has fallen by 20% per year. New Risk • Sep 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 12x cash flows per share). Share price has been volatile over the past 3 months (7.4% average weekly change). Tillkännagivande • Sep 30
Shenzhen Capchem Technology Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Shenzhen Capchem Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥35.61, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 57% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.85 per share. Reported Earnings • Aug 20
Second quarter 2024 earnings released: EPS: CN¥0.33 (vs CN¥0.36 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.33 (down from CN¥0.36 in 2Q 2023). Revenue: CN¥2.07b (up 16% from 2Q 2023). Net income: CN¥250.8m (down 7.5% from 2Q 2023). Profit margin: 12% (down from 15% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Jul 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥31.75, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.51 per share. Tillkännagivande • Jun 29
Shenzhen Capchem Technology Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024 Shenzhen Capchem Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 20, 2024 Tillkännagivande • May 18
Shenzhen Capchem Technology Co., Ltd. (SZSE:300037) commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 14, 2024. Shenzhen Capchem Technology Co., Ltd. (SZSE:300037) commences a share repurchases on May 15, 2024 under the program mandated by the shareholders in the Extraordinary General Meeting held on May 14, 2024. As per the mandate, the company is authorized to repurchase up to CNY 200 million worth of its A shares. The shares will be repurchased at a price not more than CNY 45 per share. The purpose of the program is to cancel and reduce the registered capital of the company accordingly. The program will be funded from company's own funds. Declared Dividend • May 02
Dividend increased to CN¥0.60 Dividend of CN¥0.60 is 20% higher than last year. Ex-date: 10th May 2024 Payment date: 10th May 2024 Dividend yield will be 1.8%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (70% cash payout ratio). The dividend has increased by an average of 24% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 106% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Tillkännagivande • May 02
Shenzhen Capchem Technology Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on; 10 May 2024 Shenzhen Capchem Technology Co., Ltd. announced 2023 final profit distribution plan to be implemented (A shares) of CNY 6.00000000 per 10 shares (tax included), with Record date: 09 May 2024 Ex-date: 10 May 2024; and Payment date: 10 May 2024. Reported Earnings • Apr 26
First quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.33 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.22 (down from CN¥0.33 in 1Q 2023). Revenue: CN¥1.52b (down 8.0% from 1Q 2023). Net income: CN¥165.0m (down 33% from 1Q 2023). Profit margin: 11% (down from 15% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Tillkännagivande • Apr 02
Shenzhen Capchem Technology Co., Ltd., Annual General Meeting, Apr 23, 2024 Shenzhen Capchem Technology Co., Ltd., Annual General Meeting, Apr 23, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Shenzhen, Guangdong China Reported Earnings • Apr 02
Full year 2023 earnings released: EPS: CN¥1.36 (vs CN¥2.37 in FY 2022) Full year 2023 results: EPS: CN¥1.36 (down from CN¥2.37 in FY 2022). Revenue: CN¥7.48b (down 23% from FY 2022). Net income: CN¥1.01b (down 43% from FY 2022). Profit margin: 14% (down from 18% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Tillkännagivande • Mar 30
Shenzhen Capchem Technology Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Shenzhen Capchem Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Valuation Update With 7 Day Price Move • Feb 07
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥43.98, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 4.5% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥52.75 per share. Buying Opportunity • Jan 17
Now 20% undervalued Over the last 90 days, the stock is up 7.8%. The fair value is estimated to be CN¥56.19, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 34% over the last 3 years. Earnings per share has grown by 30%. Revenue is forecast to grow by 75% in 2 years. Earnings is forecast to grow by 97% in the next 2 years. Tillkännagivande • Dec 30
Shenzhen Capchem Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024 Shenzhen Capchem Technology Co., Ltd. announced that they will report fiscal year 2023 results on Apr 02, 2024 Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.59 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.38 (down from CN¥0.59 in 3Q 2022). Revenue: CN¥2.15b (down 8.1% from 3Q 2022). Net income: CN¥280.4m (down 36% from 3Q 2022). Profit margin: 13% (down from 19% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 19
Second quarter 2023 earnings released: EPS: CN¥0.36 (vs CN¥0.66 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.36 (down from CN¥0.66 in 2Q 2022). Revenue: CN¥1.79b (down 22% from 2Q 2022). Net income: CN¥271.2m (down 45% from 2Q 2022). Profit margin: 15% (down from 22% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Jul 01
Shenzhen Capchem Technology Co., Ltd. to Report First Half, 2023 Results on Aug 22, 2023 Shenzhen Capchem Technology Co., Ltd. announced that they will report first half, 2023 results on Aug 22, 2023 Tillkännagivande • May 10
Shenzhen Capchem Technology Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 16 May 2023 Shenzhen Capchem Technology Co., Ltd. announced 2022 final profit distribution plan to be implemented (A shares) of CNY 5.00000000 per 10 shares (tax included), with Record date: 15 May 2023 Ex-date: 16 May 2023; and Payment date: 16 May 2023. Valuation Update With 7 Day Price Move • Apr 12
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥56.88, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 173% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥29.67 per share. Reported Earnings • Mar 29
Full year 2022 earnings released: EPS: CN¥2.37 (vs CN¥1.77 in FY 2021) Full year 2022 results: EPS: CN¥2.37 (up from CN¥1.77 in FY 2021). Revenue: CN¥9.66b (up 39% from FY 2021). Net income: CN¥1.76b (up 35% from FY 2021). Profit margin: 18% (in line with FY 2021). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 29
Third quarter 2022 earnings released: EPS: CN¥0.59 (vs CN¥0.58 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.59 (up from CN¥0.58 in 3Q 2021). Revenue: CN¥2.34b (up 22% from 3Q 2021). Net income: CN¥438.3m (up 1.7% from 3Q 2021). Profit margin: 19% (down from 23% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: CN¥0.66 (vs CN¥0.38 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.66 (up from CN¥0.38 in 2Q 2021). Revenue: CN¥2.28b (up 61% from 2Q 2021). Net income: CN¥492.3m (up 75% from 2Q 2021). Profit margin: 22% (up from 20% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 18%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Aug 13
Now 21% undervalued Over the last 90 days, the stock is up 27%. The fair value is estimated to be CN¥64.80, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 49% over the last 3 years. Earnings per share has grown by 54%. Revenue is forecast to grow by 50% in 2 years. Earnings is forecast to grow by 45% in the next 2 years. Buying Opportunity • Jul 09
Now 21% undervalued Over the last 90 days, the stock is up 15%. The fair value is estimated to be CN¥65.19, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 49% over the last 3 years. Earnings per share has grown by 54%. Revenue is forecast to grow by 43% in 2 years. Earnings is forecast to grow by 43% in the next 2 years. Valuation Update With 7 Day Price Move • Jun 29
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥56.14, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 369% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥63.05 per share. Upcoming Dividend • May 05
Upcoming dividend of CN¥0.68 per share Eligible shareholders must have bought the stock before 12 May 2022. Payment date: 12 May 2022. Payout ratio is a comfortable 17% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of Chinese dividend payers (2.2%). Lower than average of industry peers (1.8%). Reported Earnings • Apr 30
First quarter 2022 earnings released: EPS: CN¥1.24 (vs CN¥0.38 in 1Q 2021) First quarter 2022 results: EPS: CN¥1.24 (up from CN¥0.38 in 1Q 2021). Revenue: CN¥2.71b (up 138% from 1Q 2021). Net income: CN¥511.6m (up 229% from 1Q 2021). Profit margin: 19% (up from 14% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 22%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 01
Full year 2021 earnings released: EPS: CN¥3.18 (vs CN¥1.29 in FY 2020) Full year 2021 results: EPS: CN¥3.18 (up from CN¥1.29 in FY 2020). Revenue: CN¥6.95b (up 135% from FY 2020). Net income: CN¥1.31b (up 152% from FY 2020). Profit margin: 19% (up from 18% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 42%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year whereas the company’s share price has increased by 47% per year. Reported Earnings • Jan 23
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: CN¥3.18 (up from CN¥1.29 in FY 2020). Revenue: CN¥6.95b (up 135% from FY 2020). Net income: CN¥1.31b (up 152% from FY 2020). Profit margin: 19% (up from 18% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.2%. Over the next year, revenue is forecast to grow 55%, compared to a 40% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has increased by 57% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥1.05 (vs CN¥0.35 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥1.91b (up 136% from 3Q 2020). Net income: CN¥431.0m (up 217% from 3Q 2020). Profit margin: 23% (up from 17% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 91% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 11
Investor sentiment improved over the past week After last week's 43% share price gain to CN¥140, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 558% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥159 per share. Reported Earnings • Aug 04
Second quarter 2021 earnings released: EPS CN¥0.68 (vs CN¥0.38 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.42b (up 111% from 2Q 2020). Net income: CN¥281.4m (up 103% from 2Q 2020). Profit margin: 20% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 78% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • May 19
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥79.51, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 252% over the past three years. Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.38 (vs CN¥0.26 in 1Q 2020) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥1.14b (up 119% from 1Q 2020). Net income: CN¥155.5m (up 57% from 1Q 2020). Profit margin: 14% (down from 19% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Mar 26
Full year 2020 earnings released: EPS CN¥1.29 (vs CN¥0.86 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.96b (up 27% from FY 2019). Net income: CN¥517.8m (up 59% from FY 2019). Profit margin: 18% (up from 14% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth. Is New 90 Day High Low • Mar 10
New 90-day low: CN¥72.05 The company is down 26% from its price of CN¥97.63 on 10 December 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥34.86 per share. Is New 90 Day High Low • Feb 04
New 90-day low: CN¥77.26 The company is down 13% from its price of CN¥88.69 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥35.20 per share. Analyst Estimate Surprise Post Earnings • Jan 21
Revenue misses expectations Revenue missed analyst estimates by 2.0%. Over the next year, revenue is forecast to grow 40%, compared to a 47% growth forecast for the Chemicals industry in China. Analyst Estimate Surprise Post Earnings • Jan 19
Revenue misses expectations Revenue missed analyst estimates by 2.0%. Over the next year, revenue is forecast to grow 36%, compared to a 48% growth forecast for the Chemicals industry in China. Reported Earnings • Jan 17
Full year 2020 earnings released: EPS CN¥1.31 The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.96b (up 27% from FY 2019). Net income: CN¥519.0m (up 60% from FY 2019). Profit margin: 18% (up from 14% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 63% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jan 13
Investor sentiment deteriorated over the past week After last week's 21% share price decline to CN¥80.84, the stock is trading at a trailing P/E ratio of 69.1x, down from the previous P/E ratio of 87.4x. This compares to an average P/E of 34x in the Chemicals industry in China. Total returns to shareholders over the past three years are 311%. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥91.60, the stock is trading at a trailing P/E ratio of 78.3x, down from the previous P/E ratio of 92.9x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 358%. Is New 90 Day High Low • Dec 09
New 90-day high: CN¥99.89 The company is up 97% from its price of CN¥50.63 on 10 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥51.49 per share. Valuation Update With 7 Day Price Move • Nov 06
Market bids up stock over the past week After last week's 23% share price gain to CN¥91.95, the stock is trading at a trailing P/E ratio of 75.8x, up from the previous P/E ratio of 61.7x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past three years are 309%. Analyst Estimate Surprise Post Earnings • Oct 29
Third-quarter earnings released: Revenue beats expectations Third-quarter revenue exceeded analyst estimates by 3.1% at CN¥812.2m. Revenue is forecast to grow 35% over the next year, compared to a 44% growth forecast for the Chemicals industry in China. Reported Earnings • Oct 29
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥459.6m, up 31% from the prior year. Total revenue was CN¥2.63b over the last 12 months, up 14% from the prior year. Is New 90 Day High Low • Oct 27
New 90-day high: CN¥70.15 The company is up 24% from its price of CN¥56.64 on 29 July 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥80.08 per share. Valuation Update With 7 Day Price Move • Oct 12
Market bids up stock over the past week After last week's 19% share price gain to CN¥68.00, the stock is trading at a trailing P/E ratio of 59.9x, up from the previous P/E ratio of 50.3x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 195%. Is New 90 Day High Low • Oct 10
New 90-day high: CN¥64.50 The company is up 6.0% from its price of CN¥60.58 on 10 July 2020. The Chinese market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥74.40 per share. Tillkännagivande • Jul 18
Shenzhen Capchem Technology Co., Ltd. to Report First Half, 2020 Results on Jul 31, 2020 Shenzhen Capchem Technology Co., Ltd. announced that they will report first half, 2020 results on Jul 31, 2020